High risk features in colorectal adenomatous polyps: A multi-institutional study

被引:0
|
作者
Lee, Michael [1 ]
Ko, Huaibin Mabel [1 ]
Kudose, Satoru [1 ]
Remotti, Helen [1 ]
Choi, Won -Tak [2 ]
Salomao, Marcela A. [3 ]
Zhao, Lei [4 ]
Isidro, Raymond A. [4 ]
Liao, Xiaoyan [5 ]
Ettel, Mark G. [6 ]
Chen, Irene Y. [5 ]
Liu, Xiaoqin [5 ]
Pai, Reetesh [7 ]
Alpert, Lindsay [8 ]
Setia, Namrata [8 ]
Wu, Elizabeth [9 ]
Henn, Patrick [10 ]
Westbrook, Lindsey [10 ]
Lagana, Stephen M. [1 ]
机构
[1] Columbia Univ, Med Ctr, 630 West 168th St,VC14-240A, New York, NY 10032 USA
[2] Univ Calif San Francisco, San Francisco, CA USA
[3] Mayo Clin, Rochester, MN USA
[4] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA USA
[5] Univ Rochester, Med Ctr, Rochester, NY USA
[6] Univ Rochester, Rochester, NY USA
[7] UPMC Presbyterian Hosp, Pittsburgh, PA USA
[8] Univ Chicago, Chicago, IL USA
[9] Brown Univ, Rhode Isl Hosp, Providence, RI USA
[10] Univ Colorado, Anschutz Med Campus, Boulder, CO USA
关键词
Pathology; Adenomas; Polyps; SOCIETY TASK-FORCE; CONSENSUS UPDATE; COLONOSCOPY; CANCER; POLYPECTOMY; DYSPLASIA; MORTALITY;
D O I
10.1016/j.anndiagpath.2024.152323
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
High risk features in colorectal adenomatous polyps include size >1 cm and advanced histology: high-grade dysplasia and villous architecture. We investigated whether the diagnostic rates of advanced histology in colorectal adenomatous polyps were similar among institutions across the United States, and if not, could differences be explained by patient age, polyp size, and/or CRC rate. Nine academic institutions contributed data from three pathologists who had signed out at least 100 colorectal adenomatous polyps each from 2018 to 2019 taken from patients undergoing screening colonoscopy. For each case, we recorded patient age and sex, polyp size and location, concurrent CRC, and presence or absence of HGD and villous features. A total of 2700 polyps from 1886 patients (mean age: 61 years) were collected. One hundred twenty-four (5 %) of the 2700 polyps had advanced histology, including 35 (1 %) with HGD and 101 (4 %) with villous features. The diagnostic rate of advanced histology varied by institution from 1.7 % to 9.3 % (median: 4.3 %, standard deviation [SD]: 2.5 %). The rate of HGD ranged from 0 % to 3.3 % (median: 1 %, SD: 1.2 %), while the rate of villous architecture varied from 1 % to 8 % (median: 3.7 %, SD: 2.5 %). In a multivariate analysis, the factor most strongly associated with advanced histology was polyp size >1 cm with an odds ratio (OR) of 31.82 (95 % confidence interval [CI]: 20.52 -50.25, p < 0.05). Inter-institutional differences in the rate of polyps >1 cm likely explain some of the diagnostic variance, but pathologic subjectivity may be another contributing factor.
引用
收藏
页数:4
相关论文
共 50 条
  • [31] Dietary Risk Factors for Colorectal Adenomatous Polyps: A Mini Review
    Ramadas, A.
    Kandiah, M.
    Jabbar, F.
    Zarida, H.
    PERTANIKA JOURNAL OF SCIENCE AND TECHNOLOGY, 2010, 18 (02): : 321 - 349
  • [32] DNA repair polymorphisms and risk of colorectal adenomatous or hyperplastic polyps
    Bigler, J
    Ulrich, CM
    Kawashima, T
    Whitton, J
    Potter, JD
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2005, 14 (11) : 2501 - 2508
  • [33] Histopathological features for coexistent invasive cancer in large colorectal adenomatous polyps
    Emmanuel, A.
    Haji, A.
    Gulati, S.
    Moorhead, J.
    Papagrigoriadis, S.
    Hayee, B.
    Diaz-Cano, S.
    BJS OPEN, 2021, 5 (03):
  • [34] Diabetes mellitus and hyperglycemia control on the risk of colorectal adenomatous polyps: a retrospective cohort study
    Budzynska, Katarzyna
    Passerman, Daniel
    White-Perkins, Denise
    Rees, Della A.
    Xu, Jinping
    Lamerato, Lois
    Schooley, Susan
    BMC FAMILY PRACTICE, 2018, 19
  • [35] Diabetes mellitus and hyperglycemia control on the risk of colorectal adenomatous polyps: a retrospective cohort study
    Katarzyna Budzynska
    Daniel Passerman
    Denise White-Perkins
    Della A. Rees
    Jinping Xu
    Lois Lamerato
    Susan Schooley
    BMC Family Practice, 19
  • [36] Efficacy of regorafenib in metastatic colorectal cancer: A multi-institutional retrospective study
    Bazarbashi, M. S.
    Elshenawy, M. A.
    Kandil, M. S.
    Zahir, M.
    Shaheen, A.
    Gad, A.
    Alshaer, O.
    Alzahrani, A. M.
    Eldali, A.
    Aljubran, A.
    ANNALS OF ONCOLOGY, 2018, 29
  • [37] Efficacy of Regorafenib in Metastatic Colorectal Cancer: A Multi-institutional Retrospective Study
    Aljubran, Ali
    Elshenawy, Mahmoud A.
    Kandil, Magdy
    Zahir, Muhammed N.
    Shaheen, Ahmed
    Gad, Ahmed
    Alshaer, Omar
    Alzahrani, Ahmed
    Eldali, Abdelmonem
    Bazarbashi, Shouki
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2019, 13
  • [38] Artificial urinary sphincter in high-risk urethral scenarios: A multi-institutional study
    Tryfonyuk, L.
    Bernal, J.
    Holm, H., V
    Fisch, M.
    Ludwig, T. A.
    Angulo, J.
    Hofer, M.
    Lumen, N.
    Peterson, A.
    Brandes, S.
    Kurtzman, J.
    Simhan, J.
    Palma, Dos Reis J.
    Nikolavsky, D.
    Loh-Doyle, J.
    Venkatesan, K.
    Sandul, A.
    Martins, F.
    SCANDINAVIAN JOURNAL OF UROLOGY, 2023, 58 : 34 - 34
  • [39] Multi-Institutional Study of Clinicopathological Features of Hepatocellular Adenomas in the United States
    Patil, Pallavi
    Li, Hongjie
    Kakar, Sanjay
    Wu, Tsung-Teh
    Yeh, Matthew
    Torbenson, Michael
    Zhang, Xuchen
    Jain, Dhanpat
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 1543 - 1544
  • [40] Multi-Institutional Study of Clinicopathological Features of Hepatocellular Adenomas in the United States
    Patil, Pallavi
    Li, Hongjie
    Kakar, Sanjay
    Wu, Tsung-Teh
    Yeh, Matthew
    Torbenson, Michael
    Zhang, Xuchen
    Jain, Dhanpat
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 1543 - 1544